Clinical Trials in Pittsburgh

Showing 461-480 of 18,076 trials

Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section

NCT05380531

The purpose of this collaborative CTSA (Clinical and Translational Science Award) application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in breastfeeding mothers and their infants

Cesarean Section ComplicationsOpioid Use

Senthil Sadhasivam700 participantsStarted Dec 2022

Indianapolis, Indiana, United States • St Louis, Missouri, United States • Pittsburgh, Pennsylvania, United States +1 more locations

SUSPENDED< 1 mile

Study of Outcomes of Radiofrequency Ablation of Lung Tumors

NCT00280189

The purpose of this study is to assess short and long term outcomes after radiofrequency ablation (RFA) of pulmonary malignancies in patients who are not candidates for surgical resection. This study will evaluate the efficacy of RFA for the treatment of lung tumors by assessing its impact on local tumor control, progression free survival, overall survival, dyspnea score and quality of life (QOL).

NSCLCPulmonary Metastases

University of Pittsburgh72 participantsStarted Sep 2003

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

NCT03626688

Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World Health Organization (WHO) Group 1 PAH.

PAHPulmonary HypertensionPulmonary Arterial Hypertension+8 more

United Therapeutics687 participantsStarted Aug 2018

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +206 more locations

Personalized Perioperative Analgesia Platform (PPAP) for Cesarean Section

Study of Outcomes of Radiofrequency Ablation of Lung Tumors

A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients

Find Trials by Condition in Pittsburgh

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas

Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

SIMPLAAFY Clinical Trial

Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies

Clinical Decision Support Tool in PARDS Pilot Study

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis

Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia

A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD

N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma

Validating a Clinical Prediction Rule to Guide Manual Therapy and Exercise for Neck Pain Relief

A Study of ZW251 in Participants With Advanced Solid Tumors

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

Retinoblastoma Phase II Expanded Access Clinical Trial